Literature DB >> 11373354

Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients.

Herwig-Ulf Meier-Kriesche1, Akinlolu O Ojo1, Friedrich K Port1, Julie A Arndorfer1, Diane M Cibrik1, Bruce Kaplan1.   

Abstract

Both transplant and dialysis outcomes have improved over recent years. In addition, transplantation has been shown to confer a survival benefit over maintenance dialysis. The study presented here addresses the question of whether the survival benefit of transplantation over maintenance dialysis has changed in the most recent eras. This study was based on data collected by the United States Renal Transplant Scientific Registry and the United States Renal Data System. The study sample consisted of 104,000 patients placed on the renal transplant waiting list between 1988 and 1996, of which 73,707 subsequently received renal transplants. The annualized adjusted mortality rates per 1000 patient-years were calculated by calendar year of placement on the renal transplant waiting list and for kidney transplant recipients. The resulting data were plotted, and linear curve fitting was used to estimate the slope of the change of the adjusted mortality rates by year during the period studied, 1988 to 1996. Overall annual adjusted death rates in the wait-listed patients and transplant recipients per 1000 patient-years decreased for both groups throughout the study period. From 1989 to 1996, the relative risk (RR) for patient death had decreased by 30% for transplant recipients and 23% for wait-listed patients (RR = 0.70 and 0.77; P < 0.0001 each). Slope analysis of the cause-specific mortality rates for cardiovascular disease and infection showed nearly equivalent, linear decreases for both groups. Mortality rates have improved overall and by categories of major cause of death for both renal transplant recipients and patients on the renal transplant waiting list. These favorable trends most likely represent equal advances in transplantation, dialysis, and general medical care.

Entities:  

Mesh:

Year:  2001        PMID: 11373354     DOI: 10.1681/ASN.V1261293

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  52 in total

1.  Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?

Authors:  Erica O Miller; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-12-01       Impact factor: 5.952

2.  Minimally invasive treatment of renal transplant nephrolithiasis.

Authors:  He-jia Yuan; Dian-dong Yang; Yuan-shan Cui; Chang-ping Men; Zhen-li Gao; L Shi; Ji-tao Wu
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

Review 3.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  Living donor evaluation and exclusion: the Stanford experience.

Authors:  Jessica B Lapasia; Soo-yee Kong; Stephan Busque; John D Scandling; Glenn M Chertow; Jane C Tan
Journal:  Clin Transplant       Date:  2010-11-02       Impact factor: 2.863

Review 5.  Mass spectrometry in chronic kidney disease research.

Authors:  Michael L Merchant
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

6.  A survey of Canadian renal transplant surgeons: Use of ureteric stents and technique of the ureteroneocystotomy.

Authors:  Luke F Reynolds; Tad Kroczak; R John Honey; Kenneth T Pace; Jason Y Lee; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2018-06-19       Impact factor: 1.862

7.  Restoration of renal function does not correct impairment of uremic HDL properties.

Authors:  Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

8.  Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.

Authors:  Sunil M Kurian; Raymond Heilman; Tony S Mondala; Aleksey Nakorchevsky; Johannes A Hewel; Daniel Campbell; Elizabeth H Robison; Lin Wang; Wen Lin; Lillian Gaber; Kim Solez; Hamid Shidban; Robert Mendez; Randolph L Schaffer; Jonathan S Fisher; Stuart M Flechner; Steve R Head; Steve Horvath; John R Yates; Christopher L Marsh; Daniel R Salomon
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

9.  Pertinent issues in pretransplant recipient workup.

Authors:  Pranjal Modi
Journal:  Indian J Urol       Date:  2007-07

10.  Kidney transplant in diabetic patients: modalities, indications and results.

Authors:  Erika B Rangel; João R de Sá; Cláudio S Melaragno; Adriano M Gonzalez; Marcelo M Linhares; Alcides Salzedas; José O Medina-Pestana
Journal:  Diabetol Metab Syndr       Date:  2009-08-26       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.